For patients with solid tumors without known bone marrow involvement: peripheral absolute neutrophil count (ANC) >= 1000/mm^3
154.0
For patients with solid tumors without known bone marrow involvement: peripheral absolute neutrophil count (ANC) >= 1000/mm^3
148.0
For patients with solid tumors without known bone marrow involvement:
484.0
For patients with solid tumors without known bone marrow involvement:
81.0
For patients with solid tumors without known bone marrow involvement:
67.0
Peripheral absolute neutrophil count (ANC) >= 1000/uL for patients with solid tumors without bone marrow involvement
146.0
Peripheral absolute neutrophil count (ANC) >= 750/uL for patients with solid tumors and known bone marrow metastatic disease
146.0
Platelet count >= 50,000/uL for patients with solid tumors and known bone marrow metastatic disease
146.0
Hemoglobin >= 8.0 g/dL for patients with solid tumors and known bone marrow metastatic disease
146.0
